nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—CYP3A4—Fluticasone furoate—asthma	0.0184	0.0796	CbGbCtD
Ruxolitinib—CYP3A4—Budesonide—asthma	0.0164	0.071	CbGbCtD
Ruxolitinib—CYP3A4—Ciclesonide—asthma	0.015	0.0649	CbGbCtD
Ruxolitinib—CYP3A4—Indacaterol—asthma	0.015	0.0649	CbGbCtD
Ruxolitinib—CYP3A4—Salbutamol—asthma	0.0139	0.0603	CbGbCtD
Ruxolitinib—CYP3A4—Salmeterol—asthma	0.0139	0.0603	CbGbCtD
Ruxolitinib—CYP3A4—Flunisolide—asthma	0.0139	0.0603	CbGbCtD
Ruxolitinib—CYP3A4—Ipratropium bromide—asthma	0.0124	0.0538	CbGbCtD
Ruxolitinib—CYP3A4—Zileuton—asthma	0.0124	0.0538	CbGbCtD
Ruxolitinib—CYP3A4—Fluticasone Propionate—asthma	0.0118	0.0513	CbGbCtD
Ruxolitinib—CYP3A4—Zafirlukast—asthma	0.0109	0.0473	CbGbCtD
Ruxolitinib—CYP3A4—Tiotropium—asthma	0.0094	0.0408	CbGbCtD
Ruxolitinib—CYP3A4—Aminophylline—asthma	0.00897	0.0389	CbGbCtD
Ruxolitinib—CYP3A4—Theophylline—asthma	0.00843	0.0366	CbGbCtD
Ruxolitinib—CYP3A4—Montelukast—asthma	0.00799	0.0346	CbGbCtD
Ruxolitinib—CYP3A4—Loratadine—asthma	0.00799	0.0346	CbGbCtD
Ruxolitinib—CYP3A4—Methylprednisolone—asthma	0.00731	0.0317	CbGbCtD
Ruxolitinib—CYP3A4—Triamcinolone—asthma	0.00554	0.024	CbGbCtD
Ruxolitinib—RET—autonomic nervous system—asthma	0.005	0.0253	CbGeAlD
Ruxolitinib—CYP3A4—Betamethasone—asthma	0.00475	0.0206	CbGbCtD
Ruxolitinib—CYP3A4—Prednisolone—asthma	0.00469	0.0203	CbGbCtD
Ruxolitinib—CYP3A4—Hydrocortisone—asthma	0.00445	0.0193	CbGbCtD
Ruxolitinib—CYP3A4—Prednisone—asthma	0.00443	0.0192	CbGbCtD
Ruxolitinib—PLK1—respiratory system—asthma	0.00315	0.016	CbGeAlD
Ruxolitinib—PRKG2—smooth muscle tissue—asthma	0.00283	0.0144	CbGeAlD
Ruxolitinib—CYP3A4—Dexamethasone—asthma	0.00276	0.012	CbGbCtD
Ruxolitinib—PRKG2—cardiovascular system—asthma	0.00269	0.0137	CbGeAlD
Ruxolitinib—ANKK1—adrenal gland—asthma	0.00257	0.013	CbGeAlD
Ruxolitinib—RPS6KA6—cardiovascular system—asthma	0.00242	0.0122	CbGeAlD
Ruxolitinib—PLK3—bronchus—asthma	0.00217	0.011	CbGeAlD
Ruxolitinib—CAMK1—adrenal cortex—asthma	0.00207	0.0105	CbGeAlD
Ruxolitinib—JAK1—respiratory system—asthma	0.00202	0.0102	CbGeAlD
Ruxolitinib—PLK3—cardiovascular system—asthma	0.00202	0.0102	CbGeAlD
Ruxolitinib—PLK4—respiratory system—asthma	0.00201	0.0102	CbGeAlD
Ruxolitinib—PRKCE—adrenal gland—asthma	0.00199	0.0101	CbGeAlD
Ruxolitinib—CAMK1D—respiratory system—asthma	0.00197	0.01	CbGeAlD
Ruxolitinib—PLK3—trachea—asthma	0.00195	0.00986	CbGeAlD
Ruxolitinib—PLK1—adrenal gland—asthma	0.00191	0.00969	CbGeAlD
Ruxolitinib—HIPK2—respiratory system—asthma	0.00189	0.00956	CbGeAlD
Ruxolitinib—PRKG2—lung—asthma	0.00187	0.00947	CbGeAlD
Ruxolitinib—MAP3K19—respiratory system—asthma	0.00185	0.00937	CbGeAlD
Ruxolitinib—CLK2—respiratory system—asthma	0.00179	0.0091	CbGeAlD
Ruxolitinib—PRKCE—lung—asthma	0.00174	0.00884	CbGeAlD
Ruxolitinib—ROCK1—respiratory system—asthma	0.00174	0.00882	CbGeAlD
Ruxolitinib—DYRK1A—respiratory system—asthma	0.0017	0.0086	CbGeAlD
Ruxolitinib—JAK1—adrenal cortex—asthma	0.0017	0.00859	CbGeAlD
Ruxolitinib—BMPR2—respiratory system—asthma	0.00169	0.00857	CbGeAlD
Ruxolitinib—JAK1—epithelium—asthma	0.00169	0.00856	CbGeAlD
Ruxolitinib—RPS6KA6—lung—asthma	0.00168	0.00849	CbGeAlD
Ruxolitinib—PLK1—lung—asthma	0.00168	0.00849	CbGeAlD
Ruxolitinib—JAK1—bronchus—asthma	0.00166	0.00843	CbGeAlD
Ruxolitinib—JAK1—smooth muscle tissue—asthma	0.00163	0.00825	CbGeAlD
Ruxolitinib—CAMK1D—bronchus—asthma	0.00162	0.00823	CbGeAlD
Ruxolitinib—DAPK2—adrenal cortex—asthma	0.00162	0.0082	CbGeAlD
Ruxolitinib—PLK3—adrenal gland—asthma	0.0016	0.00809	CbGeAlD
Ruxolitinib—DAPK2—bronchus—asthma	0.00159	0.00804	CbGeAlD
Ruxolitinib—JAK1—cardiovascular system—asthma	0.00155	0.00784	CbGeAlD
Ruxolitinib—CAMK2G—respiratory system—asthma	0.00151	0.00767	CbGeAlD
Ruxolitinib—CLK2—adrenal cortex—asthma	0.00151	0.00764	CbGeAlD
Ruxolitinib—LRRK2—respiratory system—asthma	0.0015	0.0076	CbGeAlD
Ruxolitinib—JAK1—trachea—asthma	0.00149	0.00757	CbGeAlD
Ruxolitinib—DCLK1—trachea—asthma	0.00149	0.00757	CbGeAlD
Ruxolitinib—CAMK1—adrenal gland—asthma	0.00149	0.00756	CbGeAlD
Ruxolitinib—DAPK3—bronchus—asthma	0.00149	0.00756	CbGeAlD
Ruxolitinib—CLK2—bronchus—asthma	0.00148	0.00749	CbGeAlD
Ruxolitinib—DAPK3—smooth muscle tissue—asthma	0.00146	0.0074	CbGeAlD
Ruxolitinib—CAMK1D—trachea—asthma	0.00146	0.00739	CbGeAlD
Ruxolitinib—ROCK1—epithelium—asthma	0.00145	0.00737	CbGeAlD
Ruxolitinib—MARK2—adrenal gland—asthma	0.00145	0.00734	CbGeAlD
Ruxolitinib—HIPK2—cardiovascular system—asthma	0.00144	0.00732	CbGeAlD
Ruxolitinib—DAPK2—trachea—asthma	0.00142	0.00722	CbGeAlD
Ruxolitinib—ROCK1—smooth muscle tissue—asthma	0.0014	0.0071	CbGeAlD
Ruxolitinib—PLK3—lung—asthma	0.0014	0.00709	CbGeAlD
Ruxolitinib—BMPR2—bronchus—asthma	0.00139	0.00705	CbGeAlD
Ruxolitinib—DAPK3—cardiovascular system—asthma	0.00139	0.00703	CbGeAlD
Ruxolitinib—BMPR2—smooth muscle tissue—asthma	0.00136	0.0069	CbGeAlD
Ruxolitinib—LTK—lung—asthma	0.00135	0.00684	CbGeAlD
Ruxolitinib—TAOK2—adrenal gland—asthma	0.00134	0.00679	CbGeAlD
Ruxolitinib—TYK2—respiratory system—asthma	0.00134	0.00677	CbGeAlD
Ruxolitinib—ROCK1—cardiovascular system—asthma	0.00133	0.00675	CbGeAlD
Ruxolitinib—CLK2—trachea—asthma	0.00133	0.00672	CbGeAlD
Ruxolitinib—MKNK2—respiratory system—asthma	0.00132	0.00668	CbGeAlD
Ruxolitinib—CAMK1—lung—asthma	0.00131	0.00663	CbGeAlD
Ruxolitinib—DYRK1A—cardiovascular system—asthma	0.0013	0.00659	CbGeAlD
Ruxolitinib—BMPR2—cardiovascular system—asthma	0.00129	0.00656	CbGeAlD
Ruxolitinib—MARK2—lung—asthma	0.00127	0.00644	CbGeAlD
Ruxolitinib—BMP2K—bronchus—asthma	0.00124	0.00631	CbGeAlD
Ruxolitinib—JAK3—adrenal gland—asthma	0.00123	0.00624	CbGeAlD
Ruxolitinib—JAK1—adrenal gland—asthma	0.00122	0.0062	CbGeAlD
Ruxolitinib—DCLK1—adrenal gland—asthma	0.00122	0.0062	CbGeAlD
Ruxolitinib—PLK4—adrenal gland—asthma	0.00122	0.00617	CbGeAlD
Ruxolitinib—JAK2—respiratory system—asthma	0.00122	0.00616	CbGeAlD
Ruxolitinib—CAMK1D—adrenal gland—asthma	0.00119	0.00606	CbGeAlD
Ruxolitinib—NUAK2—trachea—asthma	0.00119	0.00605	CbGeAlD
Ruxolitinib—PHKG2—adrenal gland—asthma	0.00119	0.00602	CbGeAlD
Ruxolitinib—TAOK2—lung—asthma	0.00117	0.00595	CbGeAlD
Ruxolitinib—DAPK2—adrenal gland—asthma	0.00117	0.00592	CbGeAlD
Ruxolitinib—CAMK2G—cardiovascular system—asthma	0.00116	0.00587	CbGeAlD
Ruxolitinib—STK16—adrenal gland—asthma	0.00115	0.00582	CbGeAlD
Ruxolitinib—HIPK2—adrenal gland—asthma	0.00114	0.00579	CbGeAlD
Ruxolitinib—MAP3K7—adrenal cortex—asthma	0.00114	0.00579	CbGeAlD
Ruxolitinib—TYK2—adrenal cortex—asthma	0.00112	0.00568	CbGeAlD
Ruxolitinib—MAP3K7—bronchus—asthma	0.00112	0.00568	CbGeAlD
Ruxolitinib—MKNK2—adrenal cortex—asthma	0.00111	0.00561	CbGeAlD
Ruxolitinib—MKNK2—epithelium—asthma	0.0011	0.00559	CbGeAlD
Ruxolitinib—TYK2—bronchus—asthma	0.0011	0.00557	CbGeAlD
Ruxolitinib—DAPK3—adrenal gland—asthma	0.0011	0.00556	CbGeAlD
Ruxolitinib—MAP3K7—smooth muscle tissue—asthma	0.0011	0.00555	CbGeAlD
Ruxolitinib—CLK2—adrenal gland—asthma	0.00109	0.00551	CbGeAlD
Ruxolitinib—MKNK2—bronchus—asthma	0.00108	0.0055	CbGeAlD
Ruxolitinib—IRAK1—bronchus—asthma	0.00108	0.0055	CbGeAlD
Ruxolitinib—JAK3—lung—asthma	0.00108	0.00547	CbGeAlD
Ruxolitinib—TYK2—smooth muscle tissue—asthma	0.00108	0.00545	CbGeAlD
Ruxolitinib—RET—epithelium—asthma	0.00107	0.00545	CbGeAlD
Ruxolitinib—DCLK1—lung—asthma	0.00107	0.00544	CbGeAlD
Ruxolitinib—JAK1—lung—asthma	0.00107	0.00544	CbGeAlD
Ruxolitinib—TAOK3—respiratory system—asthma	0.00107	0.00541	CbGeAlD
Ruxolitinib—PLK4—lung—asthma	0.00107	0.0054	CbGeAlD
Ruxolitinib—MKNK2—smooth muscle tissue—asthma	0.00106	0.00538	CbGeAlD
Ruxolitinib—IRAK1—smooth muscle tissue—asthma	0.00106	0.00538	CbGeAlD
Ruxolitinib—CAMK1D—lung—asthma	0.00105	0.00531	CbGeAlD
Ruxolitinib—PHKG2—lung—asthma	0.00104	0.00528	CbGeAlD
Ruxolitinib—DYRK1A—adrenal gland—asthma	0.00103	0.00521	CbGeAlD
Ruxolitinib—BMPR2—adrenal gland—asthma	0.00102	0.00519	CbGeAlD
Ruxolitinib—DAPK2—lung—asthma	0.00102	0.00519	CbGeAlD
Ruxolitinib—TYK2—cardiovascular system—asthma	0.00102	0.00519	CbGeAlD
Ruxolitinib—JAK2—epithelium—asthma	0.00102	0.00515	CbGeAlD
Ruxolitinib—MKNK2—cardiovascular system—asthma	0.00101	0.00512	CbGeAlD
Ruxolitinib—STK16—lung—asthma	0.00101	0.0051	CbGeAlD
Ruxolitinib—MAP3K7—trachea—asthma	0.00101	0.0051	CbGeAlD
Ruxolitinib—HIPK2—lung—asthma	0.001	0.00508	CbGeAlD
Ruxolitinib—JAK2—bronchus—asthma	0.001	0.00507	CbGeAlD
Ruxolitinib—TYK2—trachea—asthma	0.000987	0.005	CbGeAlD
Ruxolitinib—MAP3K3—adrenal cortex—asthma	0.000983	0.00498	CbGeAlD
Ruxolitinib—MAP3K19—lung—asthma	0.000981	0.00497	CbGeAlD
Ruxolitinib—JAK2—smooth muscle tissue—asthma	0.000979	0.00496	CbGeAlD
Ruxolitinib—NUAK2—adrenal gland—asthma	0.000978	0.00496	CbGeAlD
Ruxolitinib—MKNK2—trachea—asthma	0.000974	0.00494	CbGeAlD
Ruxolitinib—MAP3K3—bronchus—asthma	0.000964	0.00489	CbGeAlD
Ruxolitinib—DAPK3—lung—asthma	0.000962	0.00488	CbGeAlD
Ruxolitinib—CLK2—lung—asthma	0.000953	0.00483	CbGeAlD
Ruxolitinib—JAK2—cardiovascular system—asthma	0.000931	0.00472	CbGeAlD
Ruxolitinib—ROCK1—lung—asthma	0.000924	0.00468	CbGeAlD
Ruxolitinib—BMP2K—adrenal gland—asthma	0.000916	0.00464	CbGeAlD
Ruxolitinib—CAMK2G—adrenal gland—asthma	0.000916	0.00464	CbGeAlD
Ruxolitinib—LRRK2—adrenal gland—asthma	0.000908	0.0046	CbGeAlD
Ruxolitinib—DYRK1A—lung—asthma	0.000901	0.00457	CbGeAlD
Ruxolitinib—JAK2—trachea—asthma	0.000898	0.00455	CbGeAlD
Ruxolitinib—BMPR2—lung—asthma	0.000897	0.00455	CbGeAlD
Ruxolitinib—MAP3K3—cardiovascular system—asthma	0.000897	0.00455	CbGeAlD
Ruxolitinib—TAOK3—adrenal cortex—asthma	0.000896	0.00454	CbGeAlD
Ruxolitinib—TAOK3—bronchus—asthma	0.000879	0.00446	CbGeAlD
Ruxolitinib—MAP3K3—trachea—asthma	0.000866	0.00439	CbGeAlD
Ruxolitinib—NUAK2—lung—asthma	0.000857	0.00435	CbGeAlD
Ruxolitinib—MAP3K2—adrenal gland—asthma	0.000832	0.00422	CbGeAlD
Ruxolitinib—MAP3K7—adrenal gland—asthma	0.000824	0.00418	CbGeAlD
Ruxolitinib—TAOK3—cardiovascular system—asthma	0.000818	0.00415	CbGeAlD
Ruxolitinib—TYK2—adrenal gland—asthma	0.000809	0.0041	CbGeAlD
Ruxolitinib—CAMK2G—lung—asthma	0.000803	0.00407	CbGeAlD
Ruxolitinib—BMP2K—lung—asthma	0.000803	0.00407	CbGeAlD
Ruxolitinib—IRAK1—adrenal gland—asthma	0.000799	0.00405	CbGeAlD
Ruxolitinib—MKNK2—adrenal gland—asthma	0.000799	0.00405	CbGeAlD
Ruxolitinib—LRRK2—lung—asthma	0.000796	0.00403	CbGeAlD
Ruxolitinib—TAOK3—trachea—asthma	0.000789	0.004	CbGeAlD
Ruxolitinib—RET—adrenal gland—asthma	0.000779	0.00395	CbGeAlD
Ruxolitinib—JAK2—adrenal gland—asthma	0.000736	0.00373	CbGeAlD
Ruxolitinib—MAP3K2—lung—asthma	0.000729	0.0037	CbGeAlD
Ruxolitinib—MAP3K7—lung—asthma	0.000722	0.00366	CbGeAlD
Ruxolitinib—MAP3K3—adrenal gland—asthma	0.00071	0.0036	CbGeAlD
Ruxolitinib—TYK2—lung—asthma	0.000709	0.0036	CbGeAlD
Ruxolitinib—MKNK2—lung—asthma	0.0007	0.00355	CbGeAlD
Ruxolitinib—IRAK1—lung—asthma	0.0007	0.00355	CbGeAlD
Ruxolitinib—TAOK3—adrenal gland—asthma	0.000647	0.00328	CbGeAlD
Ruxolitinib—JAK2—lung—asthma	0.000645	0.00327	CbGeAlD
Ruxolitinib—MAP3K3—lung—asthma	0.000622	0.00315	CbGeAlD
Ruxolitinib—TAOK3—lung—asthma	0.000567	0.00287	CbGeAlD
Ruxolitinib—Dizziness—Pirbuterol—asthma	0.000519	0.00235	CcSEcCtD
Ruxolitinib—Headache—Zileuton—asthma	0.000518	0.00234	CcSEcCtD
Ruxolitinib—Infection—Fluticasone Propionate—asthma	0.000516	0.00233	CcSEcCtD
Ruxolitinib—Infection—Salmeterol—asthma	0.000515	0.00233	CcSEcCtD
Ruxolitinib—Haematuria—Budesonide—asthma	0.000512	0.00231	CcSEcCtD
Ruxolitinib—Headache—Indacaterol—asthma	0.00051	0.0023	CcSEcCtD
Ruxolitinib—Nervous system disorder—Fluticasone Propionate—asthma	0.000509	0.0023	CcSEcCtD
Ruxolitinib—Asthenia—Zafirlukast—asthma	0.000509	0.0023	CcSEcCtD
Ruxolitinib—Nervous system disorder—Salmeterol—asthma	0.000508	0.0023	CcSEcCtD
Ruxolitinib—Epistaxis—Budesonide—asthma	0.000506	0.00229	CcSEcCtD
Ruxolitinib—Fatigue—Cromoglicic acid—asthma	0.000506	0.00229	CcSEcCtD
Ruxolitinib—Headache—Orciprenaline—asthma	0.000506	0.00229	CcSEcCtD
Ruxolitinib—Skin disorder—Fluticasone Propionate—asthma	0.000504	0.00228	CcSEcCtD
Ruxolitinib—Skin disorder—Salmeterol—asthma	0.000503	0.00227	CcSEcCtD
Ruxolitinib—Pruritus—Zafirlukast—asthma	0.000502	0.00227	CcSEcCtD
Ruxolitinib—Haemoglobin—Salbutamol—asthma	0.0005	0.00226	CcSEcCtD
Ruxolitinib—Dizziness—Fluticasone furoate—asthma	0.0005	0.00226	CcSEcCtD
Ruxolitinib—Haemorrhage—Salbutamol—asthma	0.000498	0.00225	CcSEcCtD
Ruxolitinib—Headache—Nedocromil—asthma	0.000495	0.00224	CcSEcCtD
Ruxolitinib—Headache—Pirbuterol—asthma	0.000492	0.00222	CcSEcCtD
Ruxolitinib—Infection—Aminophylline—asthma	0.000489	0.00221	CcSEcCtD
Ruxolitinib—Haemoglobin—Budesonide—asthma	0.000484	0.00219	CcSEcCtD
Ruxolitinib—Nervous system disorder—Aminophylline—asthma	0.000482	0.00218	CcSEcCtD
Ruxolitinib—Haemorrhage—Budesonide—asthma	0.000482	0.00218	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Loratadine—asthma	0.000482	0.00218	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—asthma	0.000481	0.00217	CcSEcCtD
Ruxolitinib—Pruritus—Theophylline—asthma	0.000478	0.00216	CcSEcCtD
Ruxolitinib—Contusion—Prednisone—asthma	0.000473	0.00214	CcSEcCtD
Ruxolitinib—Headache—Fluticasone furoate—asthma	0.000473	0.00214	CcSEcCtD
Ruxolitinib—Dizziness—Zafirlukast—asthma	0.000469	0.00212	CcSEcCtD
Ruxolitinib—Body temperature increased—Cromoglicic acid—asthma	0.000464	0.0021	CcSEcCtD
Ruxolitinib—Asthenia—Ciclesonide—asthma	0.000464	0.0021	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Ipratropium bromide—asthma	0.000463	0.00209	CcSEcCtD
Ruxolitinib—Fatigue—Ipratropium bromide—asthma	0.000463	0.00209	CcSEcCtD
Ruxolitinib—Infection—Tiotropium—asthma	0.000461	0.00208	CcSEcCtD
Ruxolitinib—Malnutrition—Formoterol—asthma	0.000459	0.00207	CcSEcCtD
Ruxolitinib—Malnutrition—Arformoterol—asthma	0.000459	0.00207	CcSEcCtD
Ruxolitinib—Nervous system disorder—Loratadine—asthma	0.000456	0.00206	CcSEcCtD
Ruxolitinib—Nervous system disorder—Tiotropium—asthma	0.000455	0.00206	CcSEcCtD
Ruxolitinib—Skin disorder—Loratadine—asthma	0.000451	0.00204	CcSEcCtD
Ruxolitinib—Skin disorder—Tiotropium—asthma	0.000451	0.00204	CcSEcCtD
Ruxolitinib—Dizziness—Theophylline—asthma	0.000447	0.00202	CcSEcCtD
Ruxolitinib—Dizziness—Beclomethasone—asthma	0.000447	0.00202	CcSEcCtD
Ruxolitinib—Fatigue—Salmeterol—asthma	0.000447	0.00202	CcSEcCtD
Ruxolitinib—Headache—Zafirlukast—asthma	0.000445	0.00201	CcSEcCtD
Ruxolitinib—Hypercholesterolaemia—Prednisone—asthma	0.000437	0.00197	CcSEcCtD
Ruxolitinib—Malnutrition—Salbutamol—asthma	0.000433	0.00196	CcSEcCtD
Ruxolitinib—Dizziness—Ciclesonide—asthma	0.000427	0.00193	CcSEcCtD
Ruxolitinib—Infection—Flunisolide—asthma	0.000427	0.00193	CcSEcCtD
Ruxolitinib—Flatulence—Salbutamol—asthma	0.000427	0.00193	CcSEcCtD
Ruxolitinib—Headache—Theophylline—asthma	0.000423	0.00191	CcSEcCtD
Ruxolitinib—Headache—Beclomethasone—asthma	0.000423	0.00191	CcSEcCtD
Ruxolitinib—Asthenia—Cromoglicic acid—asthma	0.000421	0.0019	CcSEcCtD
Ruxolitinib—Malnutrition—Budesonide—asthma	0.00042	0.0019	CcSEcCtD
Ruxolitinib—Flatulence—Budesonide—asthma	0.000413	0.00187	CcSEcCtD
Ruxolitinib—Body temperature increased—Fluticasone Propionate—asthma	0.00041	0.00186	CcSEcCtD
Ruxolitinib—Body temperature increased—Salmeterol—asthma	0.00041	0.00185	CcSEcCtD
Ruxolitinib—Headache—Ciclesonide—asthma	0.000405	0.00183	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Loratadine—asthma	0.000401	0.00181	CcSEcCtD
Ruxolitinib—Fatigue—Loratadine—asthma	0.000401	0.00181	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Tiotropium—asthma	0.000401	0.00181	CcSEcCtD
Ruxolitinib—Infection—Mometasone—asthma	0.000396	0.00179	CcSEcCtD
Ruxolitinib—Body temperature increased—Aminophylline—asthma	0.000389	0.00176	CcSEcCtD
Ruxolitinib—Dizziness—Cromoglicic acid—asthma	0.000388	0.00176	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Formoterol—asthma	0.000388	0.00175	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—asthma	0.000388	0.00175	CcSEcCtD
Ruxolitinib—Anaemia—Budesonide—asthma	0.000388	0.00175	CcSEcCtD
Ruxolitinib—Asthenia—Ipratropium bromide—asthma	0.000385	0.00174	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Montelukast—asthma	0.00038	0.00172	CcSEcCtD
Ruxolitinib—Pruritus—Ipratropium bromide—asthma	0.00038	0.00172	CcSEcCtD
Ruxolitinib—Infection—Formoterol—asthma	0.000372	0.00168	CcSEcCtD
Ruxolitinib—Infection—Arformoterol—asthma	0.000372	0.00168	CcSEcCtD
Ruxolitinib—Asthenia—Salmeterol—asthma	0.000372	0.00168	CcSEcCtD
Ruxolitinib—Fatigue—Flunisolide—asthma	0.000371	0.00168	CcSEcCtD
Ruxolitinib—Headache—Cromoglicic acid—asthma	0.000368	0.00166	CcSEcCtD
Ruxolitinib—Body temperature increased—Loratadine—asthma	0.000367	0.00166	CcSEcCtD
Ruxolitinib—Pruritus—Fluticasone Propionate—asthma	0.000367	0.00166	CcSEcCtD
Ruxolitinib—Nervous system disorder—Arformoterol—asthma	0.000367	0.00166	CcSEcCtD
Ruxolitinib—Nervous system disorder—Formoterol—asthma	0.000367	0.00166	CcSEcCtD
Ruxolitinib—Infection—Montelukast—asthma	0.000364	0.00165	CcSEcCtD
Ruxolitinib—Skin disorder—Arformoterol—asthma	0.000364	0.00164	CcSEcCtD
Ruxolitinib—Skin disorder—Formoterol—asthma	0.000364	0.00164	CcSEcCtD
Ruxolitinib—Nervous system disorder—Montelukast—asthma	0.00036	0.00163	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Montelukast—asthma	0.000359	0.00162	CcSEcCtD
Ruxolitinib—Skin disorder—Montelukast—asthma	0.000356	0.00161	CcSEcCtD
Ruxolitinib—Alanine aminotransferase increased—Hydrocortisone—asthma	0.000355	0.00161	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Budesonide—asthma	0.000355	0.0016	CcSEcCtD
Ruxolitinib—Dizziness—Ipratropium bromide—asthma	0.000355	0.0016	CcSEcCtD
Ruxolitinib—Infection—Salbutamol—asthma	0.000351	0.00159	CcSEcCtD
Ruxolitinib—Pruritus—Aminophylline—asthma	0.000348	0.00157	CcSEcCtD
Ruxolitinib—Nervous system disorder—Salbutamol—asthma	0.000347	0.00157	CcSEcCtD
Ruxolitinib—Fatigue—Mometasone—asthma	0.000344	0.00155	CcSEcCtD
Ruxolitinib—Skin disorder—Salbutamol—asthma	0.000343	0.00155	CcSEcCtD
Ruxolitinib—Dizziness—Fluticasone Propionate—asthma	0.000343	0.00155	CcSEcCtD
Ruxolitinib—Dizziness—Salmeterol—asthma	0.000343	0.00155	CcSEcCtD
Ruxolitinib—Infection—Budesonide—asthma	0.00034	0.00154	CcSEcCtD
Ruxolitinib—Body temperature increased—Flunisolide—asthma	0.00034	0.00154	CcSEcCtD
Ruxolitinib—Headache—Ipratropium bromide—asthma	0.000336	0.00152	CcSEcCtD
Ruxolitinib—Nervous system disorder—Budesonide—asthma	0.000336	0.00152	CcSEcCtD
Ruxolitinib—Alanine aminotransferase increased—Methylprednisolone—asthma	0.000334	0.00151	CcSEcCtD
Ruxolitinib—Asthenia—Loratadine—asthma	0.000333	0.00151	CcSEcCtD
Ruxolitinib—Skin disorder—Budesonide—asthma	0.000333	0.0015	CcSEcCtD
Ruxolitinib—Pruritus—Tiotropium—asthma	0.000328	0.00148	CcSEcCtD
Ruxolitinib—Dizziness—Aminophylline—asthma	0.000325	0.00147	CcSEcCtD
Ruxolitinib—Headache—Fluticasone Propionate—asthma	0.000325	0.00147	CcSEcCtD
Ruxolitinib—Headache—Salmeterol—asthma	0.000325	0.00147	CcSEcCtD
Ruxolitinib—Weight increased—Prednisolone—asthma	0.000325	0.00147	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Arformoterol—asthma	0.000323	0.00146	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Formoterol—asthma	0.000323	0.00146	CcSEcCtD
Ruxolitinib—Fatigue—Formoterol—asthma	0.000323	0.00146	CcSEcCtD
Ruxolitinib—Fatigue—Arformoterol—asthma	0.000323	0.00146	CcSEcCtD
Ruxolitinib—Weight increased—Hydrocortisone—asthma	0.000317	0.00143	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Montelukast—asthma	0.000317	0.00143	CcSEcCtD
Ruxolitinib—Fatigue—Montelukast—asthma	0.000316	0.00143	CcSEcCtD
Ruxolitinib—Body temperature increased—Mometasone—asthma	0.000315	0.00143	CcSEcCtD
Ruxolitinib—Weight decreased—Hydrocortisone—asthma	0.000315	0.00142	CcSEcCtD
Ruxolitinib—Infestation NOS—Hydrocortisone—asthma	0.000311	0.0014	CcSEcCtD
Ruxolitinib—Infestation—Hydrocortisone—asthma	0.000311	0.0014	CcSEcCtD
Ruxolitinib—Asthenia—Flunisolide—asthma	0.000309	0.00139	CcSEcCtD
Ruxolitinib—Headache—Aminophylline—asthma	0.000308	0.00139	CcSEcCtD
Ruxolitinib—Dizziness—Loratadine—asthma	0.000307	0.00139	CcSEcCtD
Ruxolitinib—Dizziness—Tiotropium—asthma	0.000307	0.00139	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Salbutamol—asthma	0.000305	0.00138	CcSEcCtD
Ruxolitinib—Fatigue—Salbutamol—asthma	0.000305	0.00138	CcSEcCtD
Ruxolitinib—Pruritus—Flunisolide—asthma	0.000304	0.00138	CcSEcCtD
Ruxolitinib—Gastrointestinal haemorrhage—Prednisone—asthma	0.0003	0.00135	CcSEcCtD
Ruxolitinib—Weight increased—Triamcinolone—asthma	0.000298	0.00135	CcSEcCtD
Ruxolitinib—Weight increased—Methylprednisolone—asthma	0.000298	0.00135	CcSEcCtD
Ruxolitinib—Body temperature increased—Arformoterol—asthma	0.000296	0.00134	CcSEcCtD
Ruxolitinib—Body temperature increased—Formoterol—asthma	0.000296	0.00134	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Budesonide—asthma	0.000296	0.00134	CcSEcCtD
Ruxolitinib—Fatigue—Budesonide—asthma	0.000295	0.00133	CcSEcCtD
Ruxolitinib—Infestation—Methylprednisolone—asthma	0.000292	0.00132	CcSEcCtD
Ruxolitinib—Infestation NOS—Methylprednisolone—asthma	0.000292	0.00132	CcSEcCtD
Ruxolitinib—Headache—Loratadine—asthma	0.000291	0.00132	CcSEcCtD
Ruxolitinib—Headache—Tiotropium—asthma	0.000291	0.00131	CcSEcCtD
Ruxolitinib—Body temperature increased—Montelukast—asthma	0.00029	0.00131	CcSEcCtD
Ruxolitinib—Haemoglobin—Prednisolone—asthma	0.000287	0.0013	CcSEcCtD
Ruxolitinib—Asthenia—Mometasone—asthma	0.000286	0.00129	CcSEcCtD
Ruxolitinib—Haemorrhage—Prednisolone—asthma	0.000285	0.00129	CcSEcCtD
Ruxolitinib—Dizziness—Flunisolide—asthma	0.000284	0.00129	CcSEcCtD
Ruxolitinib—Pruritus—Mometasone—asthma	0.000282	0.00128	CcSEcCtD
Ruxolitinib—Haemoglobin—Hydrocortisone—asthma	0.00028	0.00127	CcSEcCtD
Ruxolitinib—Body temperature increased—Salbutamol—asthma	0.000279	0.00126	CcSEcCtD
Ruxolitinib—Haemorrhage—Hydrocortisone—asthma	0.000279	0.00126	CcSEcCtD
Ruxolitinib—Epistaxis—Triamcinolone—asthma	0.000276	0.00125	CcSEcCtD
Ruxolitinib—Weight increased—Betamethasone—asthma	0.000271	0.00122	CcSEcCtD
Ruxolitinib—Weight increased—Dexamethasone—asthma	0.000271	0.00122	CcSEcCtD
Ruxolitinib—Body temperature increased—Budesonide—asthma	0.000271	0.00122	CcSEcCtD
Ruxolitinib—Headache—Flunisolide—asthma	0.000269	0.00122	CcSEcCtD
Ruxolitinib—Weight decreased—Betamethasone—asthma	0.000269	0.00122	CcSEcCtD
Ruxolitinib—Weight decreased—Dexamethasone—asthma	0.000269	0.00122	CcSEcCtD
Ruxolitinib—Asthenia—Arformoterol—asthma	0.000269	0.00121	CcSEcCtD
Ruxolitinib—Asthenia—Formoterol—asthma	0.000269	0.00121	CcSEcCtD
Ruxolitinib—Pruritus—Arformoterol—asthma	0.000265	0.0012	CcSEcCtD
Ruxolitinib—Pruritus—Formoterol—asthma	0.000265	0.0012	CcSEcCtD
Ruxolitinib—Alanine aminotransferase increased—Prednisone—asthma	0.000264	0.0012	CcSEcCtD
Ruxolitinib—Haemoglobin—Triamcinolone—asthma	0.000264	0.00119	CcSEcCtD
Ruxolitinib—Haemoglobin—Methylprednisolone—asthma	0.000263	0.00119	CcSEcCtD
Ruxolitinib—Asthenia—Montelukast—asthma	0.000263	0.00119	CcSEcCtD
Ruxolitinib—Haemorrhage—Triamcinolone—asthma	0.000262	0.00119	CcSEcCtD
Ruxolitinib—Haemorrhage—Methylprednisolone—asthma	0.000262	0.00118	CcSEcCtD
Ruxolitinib—Pruritus—Montelukast—asthma	0.000259	0.00117	CcSEcCtD
Ruxolitinib—Asthenia—Salbutamol—asthma	0.000254	0.00115	CcSEcCtD
Ruxolitinib—Pruritus—Salbutamol—asthma	0.00025	0.00113	CcSEcCtD
Ruxolitinib—Headache—Mometasone—asthma	0.00025	0.00113	CcSEcCtD
Ruxolitinib—Dizziness—Arformoterol—asthma	0.000248	0.00112	CcSEcCtD
Ruxolitinib—Dizziness—Formoterol—asthma	0.000248	0.00112	CcSEcCtD
Ruxolitinib—Asthenia—Budesonide—asthma	0.000246	0.00111	CcSEcCtD
Ruxolitinib—Malnutrition—Hydrocortisone—asthma	0.000243	0.0011	CcSEcCtD
Ruxolitinib—Dizziness—Montelukast—asthma	0.000243	0.0011	CcSEcCtD
Ruxolitinib—Neutropenia—Prednisone—asthma	0.000242	0.0011	CcSEcCtD
Ruxolitinib—Pruritus—Budesonide—asthma	0.000242	0.0011	CcSEcCtD
Ruxolitinib—Haemoglobin—Dexamethasone—asthma	0.000239	0.00108	CcSEcCtD
Ruxolitinib—Haemoglobin—Betamethasone—asthma	0.000239	0.00108	CcSEcCtD
Ruxolitinib—Haemorrhage—Betamethasone—asthma	0.000238	0.00108	CcSEcCtD
Ruxolitinib—Haemorrhage—Dexamethasone—asthma	0.000238	0.00108	CcSEcCtD
Ruxolitinib—Weight increased—Prednisone—asthma	0.000236	0.00107	CcSEcCtD
Ruxolitinib—Headache—Formoterol—asthma	0.000235	0.00106	CcSEcCtD
Ruxolitinib—Headache—Arformoterol—asthma	0.000235	0.00106	CcSEcCtD
Ruxolitinib—Weight decreased—Prednisone—asthma	0.000234	0.00106	CcSEcCtD
Ruxolitinib—Dizziness—Salbutamol—asthma	0.000234	0.00106	CcSEcCtD
Ruxolitinib—Headache—Montelukast—asthma	0.00023	0.00104	CcSEcCtD
Ruxolitinib—Malnutrition—Methylprednisolone—asthma	0.000228	0.00103	CcSEcCtD
Ruxolitinib—Dizziness—Budesonide—asthma	0.000226	0.00102	CcSEcCtD
Ruxolitinib—Headache—Salbutamol—asthma	0.000221	0.001	CcSEcCtD
Ruxolitinib—Headache—Budesonide—asthma	0.000215	0.00097	CcSEcCtD
Ruxolitinib—Haemoglobin—Prednisone—asthma	0.000208	0.000942	CcSEcCtD
Ruxolitinib—Haemorrhage—Prednisone—asthma	0.000207	0.000937	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	0.000205	0.000927	CcSEcCtD
Ruxolitinib—Infection—Hydrocortisone—asthma	0.000197	0.000889	CcSEcCtD
Ruxolitinib—Nervous system disorder—Hydrocortisone—asthma	0.000194	0.000878	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	0.000193	0.000871	CcSEcCtD
Ruxolitinib—Skin disorder—Hydrocortisone—asthma	0.000192	0.000869	CcSEcCtD
Ruxolitinib—Infection—Triamcinolone—asthma	0.000185	0.000837	CcSEcCtD
Ruxolitinib—Infection—Methylprednisolone—asthma	0.000185	0.000835	CcSEcCtD
Ruxolitinib—Nervous system disorder—Methylprednisolone—asthma	0.000182	0.000825	CcSEcCtD
Ruxolitinib—Skin disorder—Methylprednisolone—asthma	0.000181	0.000817	CcSEcCtD
Ruxolitinib—Malnutrition—Prednisone—asthma	0.000181	0.000816	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Hydrocortisone—asthma	0.000171	0.000773	CcSEcCtD
Ruxolitinib—Fatigue—Hydrocortisone—asthma	0.000171	0.000772	CcSEcCtD
Ruxolitinib—Infection—Betamethasone—asthma	0.000168	0.00076	CcSEcCtD
Ruxolitinib—Infection—Dexamethasone—asthma	0.000168	0.00076	CcSEcCtD
Ruxolitinib—Anaemia—Prednisone—asthma	0.000167	0.000754	CcSEcCtD
Ruxolitinib—Nervous system disorder—Dexamethasone—asthma	0.000166	0.00075	CcSEcCtD
Ruxolitinib—Nervous system disorder—Betamethasone—asthma	0.000166	0.00075	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Dexamethasone—asthma	0.000166	0.000749	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Betamethasone—asthma	0.000166	0.000749	CcSEcCtD
Ruxolitinib—Fatigue—Triamcinolone—asthma	0.000161	0.000727	CcSEcCtD
Ruxolitinib—Fatigue—Methylprednisolone—asthma	0.00016	0.000725	CcSEcCtD
Ruxolitinib—Body temperature increased—Hydrocortisone—asthma	0.000157	0.000708	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	0.000153	0.00069	CcSEcCtD
Ruxolitinib—Body temperature increased—Triamcinolone—asthma	0.000147	0.000666	CcSEcCtD
Ruxolitinib—Infection—Prednisone—asthma	0.000146	0.000662	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Dexamethasone—asthma	0.000146	0.00066	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Betamethasone—asthma	0.000146	0.00066	CcSEcCtD
Ruxolitinib—Fatigue—Betamethasone—asthma	0.000146	0.000659	CcSEcCtD
Ruxolitinib—Fatigue—Dexamethasone—asthma	0.000146	0.000659	CcSEcCtD
Ruxolitinib—Nervous system disorder—Prednisone—asthma	0.000145	0.000653	CcSEcCtD
Ruxolitinib—Skin disorder—Prednisone—asthma	0.000143	0.000647	CcSEcCtD
Ruxolitinib—Asthenia—Hydrocortisone—asthma	0.000142	0.000642	CcSEcCtD
Ruxolitinib—Pruritus—Hydrocortisone—asthma	0.00014	0.000633	CcSEcCtD
Ruxolitinib—Dizziness—Prednisolone—asthma	0.000134	0.000606	CcSEcCtD
Ruxolitinib—Asthenia—Triamcinolone—asthma	0.000134	0.000605	CcSEcCtD
Ruxolitinib—Body temperature increased—Betamethasone—asthma	0.000134	0.000605	CcSEcCtD
Ruxolitinib—Body temperature increased—Dexamethasone—asthma	0.000134	0.000605	CcSEcCtD
Ruxolitinib—Asthenia—Methylprednisolone—asthma	0.000133	0.000603	CcSEcCtD
Ruxolitinib—Pruritus—Triamcinolone—asthma	0.000132	0.000596	CcSEcCtD
Ruxolitinib—Pruritus—Methylprednisolone—asthma	0.000132	0.000595	CcSEcCtD
Ruxolitinib—Dizziness—Hydrocortisone—asthma	0.000131	0.000592	CcSEcCtD
Ruxolitinib—Fatigue—Prednisone—asthma	0.000127	0.000574	CcSEcCtD
Ruxolitinib—Headache—Prednisolone—asthma	0.000127	0.000574	CcSEcCtD
Ruxolitinib—Headache—Hydrocortisone—asthma	0.000124	0.000561	CcSEcCtD
Ruxolitinib—Dizziness—Triamcinolone—asthma	0.000123	0.000557	CcSEcCtD
Ruxolitinib—Dizziness—Methylprednisolone—asthma	0.000123	0.000556	CcSEcCtD
Ruxolitinib—Asthenia—Betamethasone—asthma	0.000121	0.000549	CcSEcCtD
Ruxolitinib—Asthenia—Dexamethasone—asthma	0.000121	0.000549	CcSEcCtD
Ruxolitinib—Pruritus—Dexamethasone—asthma	0.00012	0.000541	CcSEcCtD
Ruxolitinib—Pruritus—Betamethasone—asthma	0.00012	0.000541	CcSEcCtD
Ruxolitinib—Headache—Triamcinolone—asthma	0.000117	0.000528	CcSEcCtD
Ruxolitinib—Headache—Methylprednisolone—asthma	0.000117	0.000527	CcSEcCtD
Ruxolitinib—Body temperature increased—Prednisone—asthma	0.000116	0.000526	CcSEcCtD
Ruxolitinib—Dizziness—Dexamethasone—asthma	0.000112	0.000506	CcSEcCtD
Ruxolitinib—Dizziness—Betamethasone—asthma	0.000112	0.000506	CcSEcCtD
Ruxolitinib—Headache—Betamethasone—asthma	0.000106	0.000479	CcSEcCtD
Ruxolitinib—Headache—Dexamethasone—asthma	0.000106	0.000479	CcSEcCtD
Ruxolitinib—Asthenia—Prednisone—asthma	0.000106	0.000478	CcSEcCtD
Ruxolitinib—Pruritus—Prednisone—asthma	0.000104	0.000471	CcSEcCtD
Ruxolitinib—Dizziness—Prednisone—asthma	9.74e-05	0.00044	CcSEcCtD
Ruxolitinib—Headache—Prednisone—asthma	9.23e-05	0.000417	CcSEcCtD
Ruxolitinib—JAK2—Signaling by GPCR—POMC—asthma	4.56e-06	1.3e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—ICAM1—asthma	4.55e-06	1.3e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CD4—asthma	4.55e-06	1.3e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—AGTR1—asthma	4.54e-06	1.29e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CCR5—asthma	4.54e-06	1.29e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—EGFR—asthma	4.53e-06	1.29e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—PPP2CA—asthma	4.49e-06	1.28e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL2RA—asthma	4.48e-06	1.28e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—BCL2—asthma	4.47e-06	1.27e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—RHOA—asthma	4.47e-06	1.27e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—CCL2—asthma	4.46e-06	1.27e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—IL6—asthma	4.45e-06	1.27e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—PDGFB—asthma	4.45e-06	1.27e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—IL6R—asthma	4.44e-06	1.27e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—IL2—asthma	4.44e-06	1.27e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CXCL10—asthma	4.44e-06	1.27e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—C3—asthma	4.44e-06	1.27e-05	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—IL6—asthma	4.43e-06	1.26e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IFNG—asthma	4.43e-06	1.26e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—NOS3—asthma	4.42e-06	1.26e-05	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—RHOA—asthma	4.42e-06	1.26e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CD4—asthma	4.41e-06	1.26e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CCR5—asthma	4.41e-06	1.26e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—SERPINE1—asthma	4.39e-06	1.25e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—TNF—asthma	4.36e-06	1.24e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NTRK1—asthma	4.36e-06	1.24e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—LTA4H—asthma	4.35e-06	1.24e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL2RA—asthma	4.34e-06	1.24e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—CXCL8—asthma	4.32e-06	1.23e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—PDGFB—asthma	4.32e-06	1.23e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—SERPINE1—asthma	4.32e-06	1.23e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—ADRB2—asthma	4.31e-06	1.23e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—C3—asthma	4.31e-06	1.23e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CD4—asthma	4.28e-06	1.22e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—STAT3—asthma	4.27e-06	1.22e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—LEP—asthma	4.26e-06	1.21e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—RHOA—asthma	4.24e-06	1.21e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—IL6—asthma	4.22e-06	1.2e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—EGFR—asthma	4.21e-06	1.2e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL1B—asthma	4.2e-06	1.2e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—NOS3—asthma	4.19e-06	1.2e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—PDGFB—asthma	4.19e-06	1.19e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL2—asthma	4.18e-06	1.19e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—RHOA—asthma	4.17e-06	1.19e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—NOS2—asthma	4.17e-06	1.19e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—VEGFA—asthma	4.16e-06	1.19e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—LEP—asthma	4.13e-06	1.18e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—IL2—asthma	4.13e-06	1.18e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—NOS3—asthma	4.13e-06	1.18e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—STAT3—asthma	4.12e-06	1.17e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—IL6—asthma	4.11e-06	1.17e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—IL6—asthma	4.11e-06	1.17e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—IL6—asthma	4.1e-06	1.17e-05	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—IL6—asthma	4.08e-06	1.16e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—ITPR1—asthma	4.08e-06	1.16e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL1B—asthma	4.08e-06	1.16e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—CD4—asthma	4.07e-06	1.16e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL2—asthma	4.06e-06	1.16e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL6R—asthma	4.06e-06	1.16e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—PTGS2—asthma	4.04e-06	1.15e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—EGFR—asthma	4.04e-06	1.15e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—FN1—asthma	4.01e-06	1.14e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—RHOA—asthma	4.01e-06	1.14e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—LEP—asthma	4.01e-06	1.14e-05	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—IL6—asthma	3.98e-06	1.14e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—IL6—asthma	3.97e-06	1.13e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—TGFB1—asthma	3.96e-06	1.13e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL1B—asthma	3.95e-06	1.13e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL2—asthma	3.94e-06	1.12e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—PTEN—asthma	3.93e-06	1.12e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—MMP9—asthma	3.91e-06	1.11e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—FN1—asthma	3.9e-06	1.11e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—PTEN—asthma	3.89e-06	1.11e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—EGFR—asthma	3.88e-06	1.11e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CD86—asthma	3.88e-06	1.11e-05	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—CXCL8—asthma	3.88e-06	1.11e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—EDN1—asthma	3.85e-06	1.1e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CCL5—asthma	3.82e-06	1.09e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—TGFB1—asthma	3.82e-06	1.09e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—PTEN—asthma	3.82e-06	1.09e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PLA2G4A—asthma	3.81e-06	1.09e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ARG1—asthma	3.8e-06	1.08e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—FN1—asthma	3.78e-06	1.08e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CSF2—asthma	3.76e-06	1.07e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—IL6—asthma	3.76e-06	1.07e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—IL6R—asthma	3.75e-06	1.07e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—EGFR—asthma	3.75e-06	1.07e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CXCL8—asthma	3.72e-06	1.06e-05	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—IL2—asthma	3.71e-06	1.06e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—PTEN—asthma	3.71e-06	1.06e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—SMAD3—asthma	3.66e-06	1.04e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CXCL8—asthma	3.66e-06	1.04e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—POMC—asthma	3.66e-06	1.04e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CCL2—asthma	3.58e-06	1.02e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL6R—asthma	3.57e-06	1.02e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IL2—asthma	3.56e-06	1.01e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—POMC—asthma	3.55e-06	1.01e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—IL6—asthma	3.54e-06	1.01e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—PTEN—asthma	3.53e-06	1.01e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—CXCL8—asthma	3.52e-06	1e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—STAT3—asthma	3.52e-06	1e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—IL6—asthma	3.52e-06	1e-05	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—VEGFA—asthma	3.51e-06	1e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—SERPINE1—asthma	3.51e-06	1e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PPP2CA—asthma	3.51e-06	9.99e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IL2—asthma	3.5e-06	9.97e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—BCL2—asthma	3.49e-06	9.96e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—IL6—asthma	3.48e-06	9.92e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—STAT3—asthma	3.48e-06	9.91e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CCL2—asthma	3.47e-06	9.9e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL6R—asthma	3.46e-06	9.87e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IFNG—asthma	3.46e-06	9.87e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—POMC—asthma	3.44e-06	9.82e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CCR5—asthma	3.44e-06	9.81e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ALDH7A1—asthma	3.44e-06	9.8e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—STAT3—asthma	3.42e-06	9.74e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—EGFR—asthma	3.4e-06	9.69e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL2RA—asthma	3.39e-06	9.67e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—RHOA—asthma	3.39e-06	9.65e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CCL2—asthma	3.37e-06	9.6e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—IL2—asthma	3.37e-06	9.6e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—MMP9—asthma	3.37e-06	9.59e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—C3—asthma	3.36e-06	9.59e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL6R—asthma	3.36e-06	9.57e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—NOS3—asthma	3.35e-06	9.55e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—PTEN—asthma	3.35e-06	9.54e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CD4—asthma	3.34e-06	9.53e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—SERPINE1—asthma	3.34e-06	9.52e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—STAT3—asthma	3.31e-06	9.44e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—MMP9—asthma	3.31e-06	9.43e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ARG2—asthma	3.3e-06	9.39e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—PTEN—asthma	3.29e-06	9.38e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PDGFB—asthma	3.27e-06	9.33e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—SERPINE1—asthma	3.24e-06	9.24e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IL6—asthma	3.23e-06	9.21e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TGFB1—asthma	3.22e-06	9.19e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—RHOA—asthma	3.22e-06	9.19e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—EGFR—asthma	3.2e-06	9.12e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—NOS3—asthma	3.19e-06	9.09e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—EGFR—asthma	3.16e-06	9.01e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—STAT3—asthma	3.15e-06	8.99e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—SERPINE1—asthma	3.15e-06	8.97e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—LEP—asthma	3.13e-06	8.93e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—RHOA—asthma	3.13e-06	8.92e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—IL6—asthma	3.11e-06	8.85e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—EGFR—asthma	3.11e-06	8.85e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—NOS3—asthma	3.1e-06	8.83e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL1B—asthma	3.09e-06	8.8e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CD4—asthma	3.09e-06	8.8e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL2—asthma	3.08e-06	8.77e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—PTGS2—asthma	3.06e-06	8.74e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—RHOA—asthma	3.03e-06	8.65e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—VEGFA—asthma	3.02e-06	8.61e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—EGFR—asthma	3.01e-06	8.58e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—NOS3—asthma	3e-06	8.56e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—STAT3—asthma	2.99e-06	8.53e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—IL6—asthma	2.98e-06	8.51e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—VEGFA—asthma	2.97e-06	8.47e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—FN1—asthma	2.95e-06	8.42e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—STAT3—asthma	2.94e-06	8.39e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—TGFB1—asthma	2.92e-06	8.33e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—PTEN—asthma	2.89e-06	8.25e-06	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—IL6—asthma	2.88e-06	8.2e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—EGFR—asthma	2.87e-06	8.17e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CXCL8—asthma	2.83e-06	8.06e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TGFB1—asthma	2.77e-06	7.91e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CXCL8—asthma	2.75e-06	7.83e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ALOX5AP—asthma	2.73e-06	7.78e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ALOX15—asthma	2.73e-06	7.78e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TGFB1—asthma	2.73e-06	7.77e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—EGFR—asthma	2.72e-06	7.75e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL2—asthma	2.7e-06	7.71e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—POMC—asthma	2.69e-06	7.67e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—EGFR—asthma	2.67e-06	7.62e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—PTEN—asthma	2.67e-06	7.62e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CXCL8—asthma	2.66e-06	7.59e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CCL2—asthma	2.63e-06	7.5e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL6R—asthma	2.62e-06	7.48e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL2—asthma	2.62e-06	7.48e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—IL6—asthma	2.61e-06	7.44e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CHAT—asthma	2.61e-06	7.43e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—STAT3—asthma	2.59e-06	7.38e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—EGFR—asthma	2.58e-06	7.34e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—MMP9—asthma	2.56e-06	7.29e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL2—asthma	2.55e-06	7.26e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—PTEN—asthma	2.54e-06	7.25e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—MMP9—asthma	2.48e-06	7.08e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—PTEN—asthma	2.47e-06	7.04e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL6—asthma	2.46e-06	7.01e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—SERPINE1—asthma	2.46e-06	7.01e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—IL6—asthma	2.43e-06	6.92e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—MMP9—asthma	2.41e-06	6.87e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—PTEN—asthma	2.4e-06	6.83e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—STAT3—asthma	2.39e-06	6.81e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL6—asthma	2.39e-06	6.8e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—RHOA—asthma	2.37e-06	6.76e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—EGFR—asthma	2.35e-06	6.71e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NOS3—asthma	2.35e-06	6.69e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ALOX5—asthma	2.32e-06	6.62e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL6—asthma	2.31e-06	6.6e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—VEGFA—asthma	2.3e-06	6.55e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—STAT3—asthma	2.28e-06	6.49e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—VEGFA—asthma	2.23e-06	6.36e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—TGFB1—asthma	2.22e-06	6.32e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CARM1—asthma	2.22e-06	6.31e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—STAT3—asthma	2.21e-06	6.3e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—IL6—asthma	2.2e-06	6.28e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—DCN—asthma	2.18e-06	6.22e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—EGFR—asthma	2.17e-06	6.19e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—VEGFA—asthma	2.16e-06	6.17e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—STAT3—asthma	2.14e-06	6.11e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ALDH2—asthma	2.12e-06	6.05e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TGFB1—asthma	2.11e-06	6.01e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IL6—asthma	2.09e-06	5.96e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CXCL8—asthma	2.08e-06	5.93e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—EGFR—asthma	2.07e-06	5.89e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IL6—asthma	2.06e-06	5.86e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TGFB1—asthma	2.05e-06	5.84e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GSTT1—asthma	2.02e-06	5.76e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—EGFR—asthma	2.01e-06	5.72e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL2—asthma	1.99e-06	5.67e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TGFB1—asthma	1.99e-06	5.66e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—IL6—asthma	1.98e-06	5.64e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—EGFR—asthma	1.95e-06	5.55e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MMP9—asthma	1.88e-06	5.37e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PTEN—asthma	1.87e-06	5.33e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL6—asthma	1.81e-06	5.15e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—VEGFA—asthma	1.69e-06	4.82e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—NQO1—asthma	1.68e-06	4.79e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—STAT3—asthma	1.67e-06	4.77e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—IL6—asthma	1.67e-06	4.76e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ADCY2—asthma	1.64e-06	4.68e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL6—asthma	1.59e-06	4.53e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TGFB1—asthma	1.55e-06	4.42e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL6—asthma	1.54e-06	4.4e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—EGFR—asthma	1.52e-06	4.34e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL6—asthma	1.5e-06	4.27e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GSTP1—asthma	1.4e-06	3.99e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—HMOX1—asthma	1.38e-06	3.94e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ITPR1—asthma	1.38e-06	3.93e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CAT—asthma	1.36e-06	3.88e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PLA2G4A—asthma	1.29e-06	3.67e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GSTM1—asthma	1.29e-06	3.67e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PPP2CA—asthma	1.19e-06	3.38e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL6—asthma	1.17e-06	3.33e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—POMC—asthma	9.1e-07	2.59e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ALB—asthma	8.29e-07	2.36e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—NOS3—asthma	7.93e-07	2.26e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PTGS2—asthma	7.25e-07	2.07e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PTEN—asthma	6.33e-07	1.8e-06	CbGpPWpGaD
